Search details
1.
The impact of coding germline variants on contralateral breast cancer risk and survival.
Am J Hum Genet
; 110(3): 475-486, 2023 03 02.
Article
in English
| MEDLINE | ID: mdl-36827971
2.
A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: application to BRCA1 and BRCA2.
Hum Mutat
; 20232023.
Article
in English
| MEDLINE | ID: mdl-38725546
3.
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer.
Eur J Epidemiol
; 38(10): 1053-1068, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37789226
4.
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
Res Sq
; 2023 Feb 13.
Article
in English
| MEDLINE | ID: mdl-36824750
5.
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.
Cancers (Basel)
; 15(13)2023 Jun 23.
Article
in English
| MEDLINE | ID: mdl-37444426
6.
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
Cancer Med
; 12(15): 16142-16162, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37401034
7.
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants.
NPJ Breast Cancer
; 9(1): 37, 2023 May 12.
Article
in English
| MEDLINE | ID: mdl-37173335
8.
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.
Eur J Hum Genet
; 31(5): 578-587, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36707629
9.
(Z)-Endoxifen and Early Recurrence of Breast Cancer: An Explorative Analysis in a Prospective Brazilian Study.
J Pers Med
; 12(4)2022 Mar 22.
Article
in English
| MEDLINE | ID: mdl-35455627
10.
Subunits of BK channels promote breast cancer development and modulate responses to endocrine treatment in preclinical models.
Br J Pharmacol
; 179(12): 2906-2924, 2022 06.
Article
in English
| MEDLINE | ID: mdl-32468618
11.
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies.
J Natl Cancer Inst
; 114(12): 1706-1719, 2022 12 08.
Article
in English
| MEDLINE | ID: mdl-35723569
12.
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women.
Sci Rep
; 12(1): 6199, 2022 04 13.
Article
in English
| MEDLINE | ID: mdl-35418701
13.
Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.
JAMA Oncol
; 8(3): e216744, 2022 Mar 01.
Article
in English
| MEDLINE | ID: mdl-35084436
14.
A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 women.
Cancer Res Commun
; 2(4): 211-219, 2022 04.
Article
in English
| MEDLINE | ID: mdl-36303815
15.
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.
Sci Rep
; 11(1): 19787, 2021 10 05.
Article
in English
| MEDLINE | ID: mdl-34611289
16.
Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer.
Explor Target Antitumor Ther
; 1: 355-371, 2020.
Article
in English
| MEDLINE | ID: mdl-33210098
17.
Gene Expression Signatures of BRCAness and Tumor Inflammation Define Subgroups of Early-Stage Hormone Receptor-Positive Breast Cancer Patients.
Clin Cancer Res
; 26(24): 6523-6534, 2020 12 15.
Article
in English
| MEDLINE | ID: mdl-33008814
18.
The Influences of Adherence to Tamoxifen and CYP2D6 Pharmacogenetics on Plasma Concentrations of the Active Metabolite (Z)-Endoxifen in Breast Cancer.
Clin Transl Sci
; 13(2): 284-292, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31573754
19.
Cancer-Associated Intermediate Conductance Ca2+-Activated K⺠Channel KCa3.1.
Cancers (Basel)
; 11(1)2019 Jan 17.
Article
in English
| MEDLINE | ID: mdl-30658505
20.
Estrogen-mediated downregulation of CD24 in breast cancer cells.
Int J Cancer
; 123(1): 66-72, 2008 Jul 01.
Article
in English
| MEDLINE | ID: mdl-18404683